吡羅昔康
4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide;3,4-DIHYDRO-2-METHYL-4-OXO-N-2-PYRIDYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE;4-HYDROXY-2-METHYL-3-(PYRID-2-YL-CARBAMOYL)-2H-1,2-BENZOTHIAZINE 1,1-DIOXIDE;4-HYDROXY-2-METHYL-3-(PYRID-2-YL-CARBAMOYL)-2H-1,2-BENZOTHIAZINE 1,2-DIOXIDE;4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE;4-hydroxy-2-methyl-n-2-pyridinyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide;AURORA KA-6753;PIROXICAMUM;2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide;2h-1,2-benzothiazine-3-carboxamide,4-hydroxy-2-methyl-n-2-pyridinyl-,1,1-diox;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid;4-hydroxy-2-methyl-n-(2-pyridyl)-2h-1,2-benzothiazine-3-carboxamide-1,1-diox;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide;Artroxicam;Baxo;Bruxicam;Caliment;chf1251;CP 16171;Piroxicam;PIROXICAM(RG);1,2-benzothiazine-3-carboxamide;4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide;4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide;Erazon;Feldene;Geldene;Larapam;Pirkam;Riacen;Zunden;吡羅昔康;Pyroxycam;Roxicam;Piroftal;Roxam;Piroxicamum [INN-Latin];CHF 1251;Piroxicam (Feldene);C15H13N3O4S;13T4O6VMAM;4-Hydroxy-;CP-16171;DivK1c_000369;4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;PIROXICAM [INN];HMS1990D11;HMS2095L03;BSPBio_000221;HMS3403D11;MFCD00057317;Tox21_110231_1;SPBio_002142;Z1137167677;s1713;Bio2_000835;Piroxicam,(S);CAS-36322-90-4;KBioGR_001315;MLS001304054;GLXC-26156;A19556;4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide;3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione;36322-90-4;Reudene;NCGC00015823-01;DB00554;NCGC00257705-01;BSPBio_002460;Piroflex;NSC-757284;NCGC00015823-04;NSC-666076;NSC757284;DTXSID5021170;CHEBI:8249;PIROXICAM [USAN];KBio2_002938;P1905;Piroxicam, >=98% (TLC);Piroxicam 1.0 mg/ml in Methanol;NCGC00015823-17;SCHEMBL3703617;NCGC00015823-06;Piroxicam: Form Alpha2;NCGC00021244-07;Prestwick1_000211;Piroxicam, British Pharmacopoeia (BP) Reference Standard;Feldene (TN);AB00052074-22;Tox21_110231;4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide;MLS000069644;PIROXICAM [ORANGE BOOK];SBI-0050875.P004;PIROXICAM [MART.];AM84917;HMS3369B07;Piroxicam for system suitability;KBio2_006731;(4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide;NCGC00188982-01;4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;CCRIS 3719;Tox21_200151;(4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e;SR-01000000199-3;Bio1_001341;BCBcMAP01_000176;HMS1362D11;Prestwick2_000211;CAS_36322-90-4;AB000520...